• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗德黑兰人类免疫缺陷病毒/结核病合并感染患者的生存率

Survival Rates among Co-infected Patients with Human Immunodeficiency Virus/Tuberculosis in Tehran, Iran.

作者信息

Roshanaei Ghodratollah, Sabouri Ghannad Masoud, Poorolajal Jalal, Mohraz Minoo, Molaeipoor Leila

机构信息

Modeling of Noncommunicable Diseases Research Center, Dept. of Biostatistics and Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.

Research Center for Molecular Medicine, Dept. of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.

出版信息

Iran J Public Health. 2017 Aug;46(8):1123-1131.

PMID:28894715
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5575393/
Abstract

BACKGROUND

The number of deaths related with co-infection of tuberculosis (TB) and HIV remains inappropriately high worldwide. TB is anticipated to be the major reason of HIV-related deaths globally. This study aimed to find out and evaluate the characteristics of the possible risk factors influencing the survival time of co-infected patients with HIV/TB in Tehran the capital of Iran.

METHODS

This retrospective study was performed on the referred patients to the one of two Behavioral Diseases Counseling Centers, Imam Khomeini, and Zamzam Centers, Tehran, Iran, in 2004-2013. Data were analyzed by Cox PH model utilizing SPSS16 statistical software.

RESULTS

Multivariate analysis confirmed that the age at diagnosis (P=0.014), gender (P=0.002), sexual transmission (P=0.01), cotrimoxazole preventive therapy (P<0.001), and onset to TB after post-HIV diagnosis (P=0.01) were the parameters which had significant effects on the death of HIV/TBco-infected patients.

CONCLUSION

The results, recommend interplay between different risk factors and the risk of death in co-infected patients with HIV/TB. We presented the barriers to higher-level organizational and functional integration for commitment to interfere with the modifiable risk factors, which effect on the mortality of patients.

摘要

背景

在全球范围内,与结核病(TB)和艾滋病毒合并感染相关的死亡人数仍然高得不合常理。预计结核病将成为全球艾滋病毒相关死亡的主要原因。本研究旨在找出并评估影响伊朗首都德黑兰艾滋病毒/结核病合并感染患者生存时间的潜在风险因素的特征。

方法

这项回顾性研究针对2004年至2013年转诊至伊朗德黑兰伊玛目霍梅尼和扎姆扎姆两个行为疾病咨询中心之一的患者进行。利用SPSS16统计软件通过Cox PH模型分析数据。

结果

多变量分析证实,诊断时的年龄(P = 0.014)、性别(P = 0.002)、性传播(P = 0.01)、复方新诺明预防性治疗(P < 0.001)以及艾滋病毒诊断后发生结核病的时间(P = 0.01)是对艾滋病毒/结核病合并感染患者死亡有显著影响的参数。

结论

结果表明,不同风险因素之间存在相互作用以及艾滋病毒/结核病合并感染患者的死亡风险。我们提出了在更高层面的组织和功能整合方面存在的障碍,以致力于干预可改变的风险因素,这些因素会影响患者的死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56f8/5575393/639aadb809ac/IJPH-46-1123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56f8/5575393/639aadb809ac/IJPH-46-1123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56f8/5575393/639aadb809ac/IJPH-46-1123-g001.jpg

相似文献

1
Survival Rates among Co-infected Patients with Human Immunodeficiency Virus/Tuberculosis in Tehran, Iran.伊朗德黑兰人类免疫缺陷病毒/结核病合并感染患者的生存率
Iran J Public Health. 2017 Aug;46(8):1123-1131.
2
Predictors of tuberculosis and human immunodeficiency virus co-infection: a case-control study.结核病与人类免疫缺陷病毒合并感染的预测因素:一项病例对照研究。
Epidemiol Health. 2014 Oct 30;36:e2014024. doi: 10.4178/epih/e2014024. eCollection 2014.
3
Incidence of isolation of Mycobacterium tuberculosis from blood samples in tuberculosis patients in Imam Khomeini Hospital, Tehran, Iran.伊朗德黑兰伊玛目霍梅尼医院结核病患者血液样本中结核分枝杆菌分离率
Acta Med Iran. 2011;49(8):556-9.
4
Survival rates of human immunodeficiency virus and tuberculosis co-infected patients.人类免疫缺陷病毒与结核病合并感染患者的生存率。
Jundishapur J Microbiol. 2014 Jun;7(6):e10565. doi: 10.5812/jjm.10565. Epub 2014 Jun 1.
5
Human Immunodeficiency Virus Infection-Associated Mortality during Pulmonary Tuberculosis Treatment in Six Provinces of China.中国六个省份肺结核治疗期间与人类免疫缺陷病毒感染相关的死亡率
Biomed Environ Sci. 2015 Jun;28(6):421-8. doi: 10.3967/bes2015.059.
6
Predictors of progression to AIDS and mortality post-HIV infection: a long-term retrospective cohort study.HIV感染后进展为艾滋病及死亡的预测因素:一项长期回顾性队列研究。
AIDS Care. 2015;27(10):1205-12. doi: 10.1080/09540121.2015.1045405. Epub 2015 Jul 20.
7
HIV and tuberculosis trends and survival of coinfection in a referral center in Tehran: A 12-year study.德黑兰某转诊中心的艾滋病毒与结核病流行趋势及合并感染患者的生存率:一项为期12年的研究。
Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S16-S17. doi: 10.1016/j.ijmyco.2016.10.010. Epub 2016 Oct 27.
8
A study on factors that drive variation in the levels of social capital among people living with HIV/AIDS in Iran.一项关于伊朗艾滋病毒/艾滋病感染者社会资本水平差异驱动因素的研究。
Glob J Health Sci. 2015 Mar 30;7(3):351-7. doi: 10.5539/gjhs.v7n3p351.
9
[Feature analysis on patients died from co-infection of Mycobacterium tuberculosis and human immunodeficiency virus in Guangxi, from 2007 to 2012].[2007年至2012年广西结核分枝杆菌与人类免疫缺陷病毒合并感染死亡患者的特征分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2014 Jun;35(6):695-8.
10
Prevalence of Adverse Drug Reactions to Highly Active Antiretroviral Therapy (HAART) among HIV Positive Patients in Imam Khomeini Hospital of Tehran, Iran.伊朗德黑兰伊玛目霍梅尼医院HIV阳性患者中高效抗逆转录病毒疗法(HAART)药物不良反应的发生率
Infect Disord Drug Targets. 2017;17(2):116-119. doi: 10.2174/1871526517666170117111350.

引用本文的文献

1
Incidence of death and its predictors among TB/HIV coinfected adult patients receiving anti-retroviral therapy at Gambelia referral hospital, Southwest Ethiopia, 2022.2022年埃塞俄比亚西南部甘贝利阿转诊医院接受抗逆转录病毒治疗的结核病/艾滋病合并感染成年患者的死亡发生率及其预测因素
BMC Infect Dis. 2025 Apr 10;25(1):500. doi: 10.1186/s12879-025-10878-7.
2
Burden of mortality and its predictors among TB-HIV co-infected patients in Ethiopia: Systematic review and meta-analysis.在埃塞俄比亚,结核-艾滋病毒合并感染患者的死亡率及其预测因素的负担:系统评价和荟萃分析。
PLoS One. 2024 Nov 7;19(11):e0312698. doi: 10.1371/journal.pone.0312698. eCollection 2024.
3

本文引用的文献

1
HIV treatment cascade in tuberculosis patients.结核病患者的HIV治疗流程
Curr Opin HIV AIDS. 2015 Nov;10(6):439-46. doi: 10.1097/COH.0000000000000197.
2
The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002-2014).全球抗击艾滋病、结核病和疟疾基金通过轮次供资模式(2002 - 2014年)在减少伤害方面的投资。
Int J Drug Policy. 2016 Jan;27:132-7. doi: 10.1016/j.drugpo.2015.08.001. Epub 2015 Aug 13.
3
The Effect of Early Initiation of Antiretroviral Therapy in TB/HIV-Coinfected Patients: A Systematic Review and Meta-Analysis.
Dynamics of Matricellular Protein Levels in Blood Predict Recovery in Patients with Human Immunodeficiency Virus-Tuberculosis Coinfection.
基质细胞蛋白水平在血液中的动态变化可预测人类免疫缺陷病毒-结核病合并感染患者的恢复情况。
Viruses. 2024 Apr 24;16(5):664. doi: 10.3390/v16050664.
4
Survival Rate and Predictors of Mortality Among TB-HIV Co-Infected Patients During Tuberculosis Treatment at Public Health Facilities in Bahir Dar City, Northwest Ethiopia.埃塞俄比亚西北部巴赫达尔市公共卫生机构中结核病治疗期间结核-艾滋病毒合并感染患者的生存率及死亡率预测因素
Infect Drug Resist. 2024 Apr 9;17:1385-1395. doi: 10.2147/IDR.S446020. eCollection 2024.
5
Joint Modeling of Longitudinal Outcome and Competing Risks: Application to HIV/AIDS Data.纵向结局和竞争风险的联合建模:在 HIV/AIDS 数据中的应用。
J Res Health Sci. 2023 Mar;23(1):e00571. doi: 10.34172/jrhs.2023.106.
6
Survival rate and predictors of mortality among TB/HIV co-infected adult patients: retrospective cohort study.结核病/艾滋病病毒合并感染成年患者的生存率和死亡预测因素:回顾性队列研究。
Sci Rep. 2022 Nov 1;12(1):18360. doi: 10.1038/s41598-022-23316-4.
7
Modeling Survival Time to Death Among TB and HIV Co-infected Adult Patients: an Institution-Based Retrospective Cohort Study.结核和艾滋病毒合并感染成人患者死亡生存时间建模:基于机构的回顾性队列研究。
J Racial Ethn Health Disparities. 2023 Aug;10(4):1616-1628. doi: 10.1007/s40615-022-01348-w. Epub 2022 Jun 13.
抗逆转录病毒疗法早期启动对结核病/艾滋病病毒合并感染患者的影响:一项系统评价和荟萃分析。
J Int Assoc Provid AIDS Care. 2015 Nov-Dec;14(6):560-70. doi: 10.1177/2325957415599210. Epub 2015 Aug 19.
4
A Century of Tuberculosis Epidemiology in the Northern and Southern Hemisphere: The Differential Impact of Control Interventions.北半球和南半球结核病流行病学百年:控制干预措施的不同影响
PLoS One. 2015 Aug 19;10(8):e0135179. doi: 10.1371/journal.pone.0135179. eCollection 2015.
5
Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy.联合抗逆转录病毒治疗时代美国感染艾滋病毒的青年和年轻成年人并发症及死亡率的变化趋势
Clin Infect Dis. 2015 Dec 15;61(12):1850-61. doi: 10.1093/cid/civ687. Epub 2015 Aug 12.
6
Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study.异烟肼预防性治疗对HIV感染者结核病或死亡的影响:一项回顾性队列研究
BMC Infect Dis. 2015 Aug 13;15:334. doi: 10.1186/s12879-015-1089-3.
7
Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis.资源有限环境下HIV感染成人和儿童尸检研究中结核病的患病率:一项系统评价和荟萃分析。
AIDS. 2015 Sep 24;29(15):1987-2002. doi: 10.1097/QAD.0000000000000802.
8
Predictors of progression to AIDS and mortality post-HIV infection: a long-term retrospective cohort study.HIV感染后进展为艾滋病及死亡的预测因素:一项长期回顾性队列研究。
AIDS Care. 2015;27(10):1205-12. doi: 10.1080/09540121.2015.1045405. Epub 2015 Jul 20.
9
Impact of TB on the survival of people living with HIV infection in England, Wales and Northern Ireland.英格兰、威尔士和北爱尔兰的结核病对艾滋病毒感染者生存状况的影响。
Thorax. 2015 Jun;70(6):566-73. doi: 10.1136/thoraxjnl-2014-206452. Epub 2015 Mar 24.
10
Survival rates of human immunodeficiency virus and tuberculosis co-infected patients.人类免疫缺陷病毒与结核病合并感染患者的生存率。
Jundishapur J Microbiol. 2014 Jun;7(6):e10565. doi: 10.5812/jjm.10565. Epub 2014 Jun 1.